1-2 of 2
Hironobu Kitazawa, MD
Close
Sort by
Journal Articles

Risk Factors for Donor-Type Aplasia after Bone Marrow Transplant in Children with Acquired Bone Marrow Failure

Asahito Hama, Hideki Muramatsu, MD PhD, Atsushi Narita, MD PhD, Hironobu Kitazawa, MD, Motoharu Hamada, MD, Shinsuke Kataoka, MD, Norihiro Murakami, MD, Daisuke Ichikawa, MD, Rieko Taniguchi, MD, Daiei Kojima, MD, Kyogo Suzuki, MD, Eri Nishikawa, MD PhD, Yusuke Okuno, MD PhD, Nozomu Kawashima, MD PhD, Nobuhiro Nishio, MD PhD, Masafumi Ito, MD PhD, Seiji Kojima, MD PhD, Yoshiyuki Takahashi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2461.
https://doi.org/10.1182/blood.V130.Suppl_1.2461.2461
Published: 2017
Journal Articles

Durable Remission after Salvage Chemotherapy with Combining Bortezomib and Vorinostat Followed By CD19 CAR-T Therapy in a Patient with MLL-Rearranged ALL after Early Relapse Post Allogeneic Hematopoietic Stem Cell Transplantation

Nobuhiro Nishio, MD PhD, Kai Wang, MDPhD, Kotaro Narita, MD, Shinsuke Kataoka, MD, Hironobu Kitazawa, MD, Motoharu Hamada, MD, Daisuke Ichikawa, MD, Rieko Taniguchi, MD, Norihiro Murakami, MD, Daiei Kojima, MD, Kyogo Suzuki, MD, Nozomu Kawashima, MD PhD, Eri Nishikawa, MD PhD, Yusuke Okuno, MD PhD, Atsushi Narita, MD PhD, Hideki Muramatsu, MD PhD, Asahito Hama, Shih-Ting Tsao, MSc, Maoquan Qin, MDPhD, Huyong Zheng, MD PhD, Lung-Ji Chang, PhD, Seiji Kojima, MD PhD, Yoshiyuki Takahashi, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3334.
https://doi.org/10.1182/blood.V130.Suppl_1.3334.3334
Published: 2017